Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 255

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 255
---
 which terms are further
set forth below under the subheading “(ii) Initial Closing with JAK”), (b) a warrant to purchase 1,325,301 Class A Ordinary
Shares of the Company, no par value (“Class A Shares” and such warrant, the Series A Warrant), and (c) a warrant to purchase
180,722 Class B Ordinary Shares of the Company, no par value (“Class B Shares” and such warrant, the Series B Warrant, and
the Series B Warrants, together with the Series A Warrants, the “Warrants”); and (ii) the Company may require each Buyer
(or each Buyer may require the Company, as applicable) to participate in the sale of (a) one or more additional convertible notes (which
aggregate original principal amount for all additional convertible notes shall not exceed $9,500,000) (the “Additional Notes,”
and, together with the Initial Note, the “Notes”).

On August 12, 2024, the Company
and JAK consummated the Initial Closing. The Initial Note sold to JAK in connection with the Securities Purchase Agreement bears an interest
rate of 14.75% per annum and is convertible into the Company’s Class A Shares as follows: the Conversion Amount (as defined below)
into validly issued, fully paid and non-assessable Class A at the Conversion Rate determined by dividing the aggregate of the principal
sum plus the interest rates (including late interest charges, if any) and the Make-Whole Amount, if any, by conversion price of $0.83.

At the Initial Closing, the
Company also sold to JAK a Series A Warrant to purchase 1,325,301 Class A Shares and a Series B Warrant to purchase 180,722 Class B Shares.

Additionally, in connection
with the Securities Purchase Agreement, the Company entered into amendment and exchange agreements with certain holders of its convertible
promissory notes (the “Existing Notes” and each of such amendment and exchange agreements, “Amendment and Exchange
Agreement”), pursuant to which the Company will exchange the Existing Notes by issuing, among other things, (i) senior convertible
notes in the aggregate principal amount of $2,700,000 (the “Exchange Notes”) and (b) a series of warrants to initially acquire
up to a certain number of ordinary shares to the holders of the Existing Notes set forth therein or in the Amendment and Exchange Agreement
(the “